{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:41:29Z","timestamp":1795030889064,"version":"4.10.2"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013317","name":"Shanxi Provincial Key Research and Development Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.cytogfr.2021.12.002","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T11:51:18Z","timestamp":1639396278000},"page":"12-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Participation of interferons in psoriatic inflammation"],"prefix":"10.1016","volume":"64","author":[{"given":"Hanjiang","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"927","key":"10.1016\/j.cytogfr.2021.12.002_bib1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cytogfr.2014.10.011","article-title":"Type I IFN family members: similarity, differences and interaction","volume":"26","author":"Capobianchi","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.immuni.2012.04.011","article-title":"Commensal bacteria calibrate the activation threshold of innate antiviral immunity","volume":"37","author":"Abt","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2021.12.002_bib4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-Gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front. Immunol."},{"issue":"5877","key":"10.1016\/j.cytogfr.2021.12.002_bib5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/298859a0","article-title":"Structure of the human immune interferon gene","volume":"298","author":"Gray","year":"1982","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.cytogfr.2021.12.002_bib6","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1073\/pnas.92.12.5401","article-title":"Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain","volume":"92","author":"Marsters","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.12.002_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12250-020-00330-2","article-title":"Herpesviruses and the Type III Interferon System","volume":"36","author":"Yin","year":"2021","journal-title":"Virol. Sin."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.12.002_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.12.002_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2021.12.002_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2018.11.022","article-title":"The influence of interferon on healthy and diseased skin","volume":"132","author":"Hile","year":"2020","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.12.002_bib13","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028423","article-title":"The interferon (IFN) class of cytokines and the IFN regulatory factor (IRF) transcription factor family","volume":"10","author":"Negishi","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.12.002_bib14","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jid.2017.03.041","article-title":"STING is involved in antiviral immune response against VZV infection via the induction of type I and III IFN pathways","volume":"137","author":"Kim","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.12.002_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/sji.12323","article-title":"Suppressor of cytokine signaling 3 Expression induced by Varicella-Zoster virus infection results in the modulation of virus replication","volume":"82","author":"Choi","year":"2015","journal-title":"Scand. J. Immunol."},{"issue":"21","key":"10.1016\/j.cytogfr.2021.12.002_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01151-18","article-title":"Distinctive roles for type I and type II interferons and interferon regulatory factors in the host cell defense against Varicella-Zoster virus","volume":"92","author":"Sen","year":"2018","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.12.002_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004901","article-title":"Varicella viruses inhibit interferon-stimulated JAK-STAT signaling through multiple mechanisms","volume":"11","author":"Verweij","year":"2015","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.12.002_bib18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.13075\/ijomeh.1896.01513","article-title":"Analysis of molecular markers as IL-12, IL-22 and IFN-\u03b3 in correlation with a clinical course in patients with psoriasis","volume":"33","author":"Kutwin","year":"2020","journal-title":"Int. J. Occup. Med. Environ. Health"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.12.002_bib19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.abd.2020.11.007","article-title":"Enhanced serum interferon-lambda 1 interleukin-29 levels in patients with psoriasis vulgaris","volume":"96","author":"Fu","year":"2021","journal-title":"An. Bras. Dermatol."},{"issue":"8","key":"10.1016\/j.cytogfr.2021.12.002_bib20","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/jdv.12240","article-title":"Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway","volume":"28","author":"Balato","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.12.002_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107904","article-title":"Inhibition of inflammatory and proliferative responses of human keratinocytes exposed to the sesquiterpene lactones dehydrocostuslactone and costunolide","volume":"9","author":"Scarponi","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jaci.2015.01.033","article-title":"Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis","volume":"136","author":"Mashiko","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"23","key":"10.1016\/j.cytogfr.2021.12.002_bib23","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.1158\/1078-0432.CCR-09-1425","article-title":"Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma","volume":"15","author":"George","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.12.002_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/scd.2019.0150","article-title":"Keratinocytes derived from patient-specific induced pluripotent stem cells recapitulate the genetic signature of psoriasis disease","volume":"29","author":"Ali","year":"2020","journal-title":"Stem Cells Dev."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.12.002_bib26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jid.2019.12.015","article-title":"Differences in staining for neutrophil elastase and its controlling inhibitor SLPI reveal heterogeneity among neutrophils in psoriasis","volume":"140","author":"Skrzeczynska-Moncznik","year":"2020","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.det.2014.09.002","article-title":"The immunopathogenesis of psoriasis","volume":"33","author":"Kim","year":"2015","journal-title":"Dermatol. Clin."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.12.002_bib28","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/jid.2014.146","article-title":"Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients","volume":"134","author":"Teunissen","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.12.002_bib29","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.12.002_bib30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0923-1811(00)00120-1","article-title":"Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system","volume":"24","author":"Nickoloff","year":"2000","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/eji.200535243","article-title":"CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation","volume":"36","author":"Ottaviani","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/jid.2014.383","article-title":"Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6","volume":"135","author":"Wu","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris","volume":"199","author":"Lee","year":"2004","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41467-017-02466-4","article-title":"TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis","volume":"9","author":"Conrad","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2021.12.002_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/bs.acc.2020.04.004","article-title":"Cytokines in psoriasis","volume":"100","author":"de Alcantara","year":"2021","journal-title":"Adv. Clin. Chem."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5114\/pdia.2014.40920","article-title":"Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis","volume":"31","author":"Nedoszytko","year":"2014","journal-title":"Postepy Dermatol. Alergol."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.12.002_bib37","first-page":"1864","article-title":"Interferon-beta sensitizes human malignant melanoma cells to temozolomide-induced apoptosis and autophagy","volume":"54","author":"Makita","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/15569527.2015.1020545","article-title":"Exacerbation of psoriasis induced by interferon-alpha treatment for melanoma","volume":"35","author":"Tas","year":"2016","journal-title":"Cutan. Ocul. Toxicol."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.12.002_bib39","doi-asserted-by":"crossref","first-page":"14951","DOI":"10.3390\/ijms160714951","article-title":"Cutaneous adverse events associated with interferon-beta treatment of multiple sclerosis","volume":"16","author":"Kolb-Maurer","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib40","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1111\/pde.13418","article-title":"Interferon-alpha induced psoriasis in a teenager","volume":"35","author":"Mendieta","year":"2018","journal-title":"Pediatr. Dermatol."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.12.002_bib41","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and Type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1684\/ejd.2015.2602","article-title":"Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient","volume":"26","author":"Amschler","year":"2016","journal-title":"Eur. J. Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jdermsci.2016.06.003","article-title":"Distinctive downmodulation of plasmacytoid dendritic cell functions by vitamin D3 analogue calcipotriol","volume":"84","author":"Suzuki","year":"2016","journal-title":"J. Dermatol. Sci."},{"issue":"10068","key":"10.1016\/j.cytogfr.2021.12.002_bib44","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(16)32127-4","article-title":"An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Warren","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.12.002_bib45","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/0394632016662475","article-title":"Expression of sirtuins 1, 6, tumor necrosis factor, and interferon-gamma in psoriatic patients","volume":"29","author":"Rasheed","year":"2016","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.cytogfr.2021.12.002_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2147\/CCID.S218243","article-title":"Interferon kappa is up-regulated in psoriasis and it up-regulates psoriasis-associated cytokines in vivo","volume":"12","author":"Li","year":"2019","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.cytogfr.2021.12.002_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/268257","article-title":"Serum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis","volume":"2014","author":"Hwang","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.12.002_bib48","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5455\/medarh.2018.72.410-413","article-title":"Serum concentrations of interferon gamma (IFN-gamma) in patients with psoriasis: correlation with clinical type and severity of the disease","volume":"72","author":"Kurtovic","year":"2018","journal-title":"Med. Arch."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.12.002_bib49","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jid.2016.06.608","article-title":"Therapeutic elimination of the Type 1 interferon receptor for treating psoriatic skin inflammation","volume":"136","author":"Gui","year":"2016","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/imr.12001","article-title":"Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation","volume":"250","author":"Piehler","year":"2012","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.immuni.2016.06.021","article-title":"Antimicrobial peptide LL37 and MAVS signaling drive interferon-beta production by epidermal keratinocytes during skin injury","volume":"45","author":"Zhang","year":"2016","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.cytogfr.2021.12.002_bib52","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.4049\/jimmunol.179.5.3249","article-title":"Genetic control directed toward spontaneous IFN-alpha\/IFN-beta responses and downstream IFN-gamma expression influences the pathogenesis of a murine psoriasis-like skin disease","volume":"179","author":"Arakura","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.12.002_bib53","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/path.1581","article-title":"In situ demonstration of CD40- and CD154-positive cells in psoriatic lesions and keratinocyte production of chemokines by CD40 ligation in vitro","volume":"203","author":"Pasch","year":"2004","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib54","doi-asserted-by":"crossref","first-page":"25381","DOI":"10.1038\/srep25381","article-title":"Up-regulation of Interferon-inducible protein 16 contributes to psoriasis by modulating chemokine production in keratinocytes","volume":"6","author":"Cao","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.12.002_bib55","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.celrep.2019.09.069","article-title":"STING-mediated IFI16 degradation negatively controls type I interferon production","volume":"29","author":"Li","year":"2019","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.12.002_bib56","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.12.002_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176994","article-title":"STAT2 is involved in the pathogenesis of psoriasis by promoting CXCL11 and CCL5 production by keratinocytes","volume":"12","author":"Johansen","year":"2017","journal-title":"PLoS One"},{"issue":"7162","key":"10.1016\/j.cytogfr.2021.12.002_bib58","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/jid.2011.259","article-title":"Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands","volume":"132","author":"Morizane","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.cytogfr.2021.12.002_bib62","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/jid.2011.468","article-title":"IFN-alpha enhances IL-22 receptor expression in keratinocytes: a possible role in the development of psoriasis","volume":"132","author":"Tohyama","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib63","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/eji.201747017","article-title":"Bcl-3 induced by IL-22 via STAT3 activation acts as a potentiator of psoriasis-related gene expression in epidermal keratinocytes","volume":"48","author":"Tohyama","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib64","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jid.2017.08.041","article-title":"Toll-like receptor-mediated upregulation of CXCL16 in psoriasis orchestrates neutrophil activation","volume":"138","author":"Steffen","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cytogfr.2021.12.002_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7897263","article-title":"Selective immunomodulation of inflammatory pathways in keratinocytes by the Janus Kinase (JAK) inhibitor tofacitinib: implications for the employment of JAK-targeting drugs in psoriasis","volume":"2018","author":"Morelli","year":"2018","journal-title":"J Immunol Res"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.12.002_bib66","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.4049\/jimmunol.1001426","volume":"185","author":"Madonna","year":"2010","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib67","first-page":"496","article-title":"The synergistic activities of the combination of tumour necrosis factor-alpha, interleukin-17A and interferon-gamma in epidermal keratinocytes","volume":"179","author":"Morizane","year":"2018","journal-title":"Br. J Dermatol."},{"key":"10.1016\/j.cytogfr.2021.12.002_bib68","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3389\/fimmu.2019.01162","article-title":"Interleukin-36 in infectious and inflammatory skin diseases","volume":"10","author":"Buhl","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2021.12.002_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155391","article-title":"Involvement of the cytokine TWEAK in the pathogenesis of psoriasis vulgaris, pustular psoriasis, and erythrodermic psoriasis","volume":"138","author":"Wang","year":"2021","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.cytogfr.2021.12.002_bib70","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41419-018-0820-6","article-title":"Fn14 deficiency ameliorates psoriasis-like skin disease in a murine model","volume":"9","author":"Peng","year":"2018","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.12.002_bib71","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jaci.2020.12.657","article-title":"Cross-talk between IFN-\u03b3 and TWEAK through miR-149 amplifies skin inflammation in psoriasis","volume":"147","author":"Srivastava","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.12.002_bib72","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/jid.2013.364","article-title":"Interferon-gamma decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis","volume":"134","author":"Tawada","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.12.002_bib73","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/jid.2013.440","article-title":"The adverse effect of IFN gamma on stratum corneum structure and function in psoriasis and atopic dermatitis","volume":"134","author":"Feingold","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.12.002_bib74","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.jid.5700716","article-title":"Differential regulation of karyopherin alpha 2 expression by TGF-beta1 and IFN-gamma in normal human epidermal keratinocytes: evident contribution of KPNA2 for nuclear translocation of IRF-1","volume":"127","author":"Umegaki","year":"2007","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.12.002_bib75","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00403-017-1722-7","article-title":"Can signal peptide-CUB-EGF domain-containing protein (SCUBE) levels be a marker of angiogenesis in patients with psoriasis?","volume":"309","author":"Capkin","year":"2017","journal-title":"Arch. Dermatol. Res."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.12.002_bib76","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000516110","article-title":"Skin surface protein detection by transdermal analysis patches in pediatric psoriasis","volume":"34","author":"Schaap","year":"2021","journal-title":"Skin Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib77","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1582-4934.2007.00112.x","article-title":"Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF","volume":"12","author":"Man","year":"2008","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.12.002_bib78","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","article-title":"Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition","volume":"19","author":"Holmes","year":"2007","journal-title":"Cell Signal."},{"issue":"12","key":"10.1016\/j.cytogfr.2021.12.002_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145498","article-title":"IMQ induced K14-VEGF mouse: a stable and long-term mouse model of psoriasis-like inflammation","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cytogfr.2021.12.002_bib80","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1365-2133.2009.09439.x","article-title":"Vasoactive intestinal peptide and inflammatory cytokines enhance vascular endothelial growth factor production from epidermal keratinocytes","volume":"161","author":"Kakurai","year":"2009","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.12.002_bib81","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.it.2004.02.006","article-title":"CXC chemokines: the regulatory link between inflammation and angiogenesis","volume":"25","author":"Romagnani","year":"2004","journal-title":"Trends Immunol."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.12.002_bib82","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/labinvest.3700453","article-title":"TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis","volume":"86","author":"Loos","year":"2006","journal-title":"Lab. Invest."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.12.002_bib83","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/exd.12709","article-title":"CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin","volume":"24","author":"Brunner","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"12","key":"10.1016\/j.cytogfr.2021.12.002_bib84","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.4049\/jimmunol.164.12.6621","article-title":"Up-regulation of macrophage inflammatory protein-3 alpha\/CCL20 and CC chemokine receptor 6 in psoriasis","volume":"164","author":"Homey","year":"2000","journal-title":"J. Immunol."},{"issue":"15","key":"10.1016\/j.cytogfr.2021.12.002_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155363","article-title":"Changes in proteome of fibroblasts isolated from psoriatic skin lesions","volume":"21","author":"G\u0119gotek","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.cytogfr.2021.12.002_bib86","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s004030000188","article-title":"Involvement of insulin-like growth factor-I in psoriasis as a paracrine growth factor: dermal fibroblasts play a regulatory role in developing psoriatic lesions","volume":"292","author":"Miura","year":"2000","journal-title":"Arch. Dermatol. Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib87","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12964-018-0271-9","article-title":"MicroRNA let-7b inhibits keratinocyte differentiation by targeting IL-6 mediated ERK signaling in psoriasis","volume":"16","author":"Wu","year":"2018","journal-title":"Cell Commun. Signal."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.12.002_bib88","first-page":"3789","article-title":"Astilbin emulsion improves guinea pig lesions in a psoriasis-like model by suppressing IL-6 and IL-22 via p38 MAPK","volume":"17","author":"Yu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.cytogfr.2021.12.002_bib89","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/eji.1830220835","article-title":"Synergistic induction of interleukin-6 by tumor necrosis factor and lithium chloride in mice: possible role in the triggering and exacerbation of psoriasis by lithium treatment","volume":"22","author":"Beyaert","year":"1992","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.12.002_bib90","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s004030050450","article-title":"Psoriatic fibroblasts secrete lower amounts of IL-6 than healthy fibroblasts before and after stimulation with TNF-alpha","volume":"291","author":"Fransson","year":"1999","journal-title":"Arch. Dermatol. Res."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.12.002_bib91","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1084\/jem.20160258","article-title":"Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a","volume":"213","author":"Cheung","year":"2016","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib92","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/path.3996","article-title":"Psoriasis in humans is associated with down-regulation of galectins in dendritic cells","volume":"228","author":"de la Fuente","year":"2012","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jid.2008.194","article-title":"Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells","volume":"129","author":"Zaba","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.12.002_bib94","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20090480","article-title":"Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8","volume":"206","author":"Ganguly","year":"2009","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib95","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/ijms19010179","article-title":"Scanning the immunopathogenesis of psoriasis","volume":"19","author":"Chiricozzi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.cytogfr.2021.12.002_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57080754","article-title":"The role of chemokines in psoriasis-an overview","volume":"57","author":"Zdanowska","year":"2021","journal-title":"Medicina"},{"issue":"10","key":"10.1016\/j.cytogfr.2021.12.002_bib97","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/jid.2010.165","article-title":"A subpopulation of CD163-positive macrophages is classically activated in psoriasis","volume":"130","author":"Fuentes-Duculan","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.12.002_bib98","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cellsig.2009.01.005","article-title":"Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways","volume":"21","author":"Sanmiguel","year":"2009","journal-title":"Cell Signal."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.12.002_bib99","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.2353\/ajpath.2007.070281","article-title":"Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation?","volume":"171","author":"Scheler","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cytogfr.2021.12.002_bib100","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cyto.2017.12.010","article-title":"A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis","volume":"110","author":"Behfar","year":"2018","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.cytogfr.2021.12.002_bib101","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/jcp.24643","article-title":"CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes","volume":"229","author":"Karakawa","year":"2014","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib102","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s13075-019-2067-8","article-title":"Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice","volume":"21","author":"Nomura","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.12.002_bib103","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/exd.13995","article-title":"Mannan-binding lectin promotes keratinocyte to produce CXCL1 and enhances neutrophil infiltration at the early stages of psoriasis","volume":"28","author":"Zeng","year":"2019","journal-title":"Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib104","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/cei.13525","article-title":"Type I interferon regulates cytokine-delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression","volume":"203","author":"Glennon-Alty","year":"2021","journal-title":"Clin. Exp. Immunol."},{"issue":"1\u20133","key":"10.1016\/j.cytogfr.2021.12.002_bib105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2013.05.041","article-title":"Rhododendrin ameliorates skin inflammation through inhibition of NF-kappaB, MAPK, and PI3K\/Akt signaling","volume":"714","author":"Jeon","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.12.002_bib106","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.4049\/jimmunol.165.7.4076","article-title":"Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells","volume":"165","author":"Bonish","year":"2000","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib107","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jdermsci.2017.12.014","article-title":"IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation","volume":"90","author":"Kawaguchi","year":"2018","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.12.002_bib108","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaad.2009.05.042","article-title":"A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis","volume":"62","author":"Bissonnette","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib109","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1084\/jem.20080129","article-title":"Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment","volume":"206","author":"Albanesi","year":"2009","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaci.2014.05.046","article-title":"Humanized anti-IFN-\u03b3 (HuZAF) in the treatment of psoriasis","volume":"135","author":"Harden","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"16","key":"10.1016\/j.cytogfr.2021.12.002_bib111","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa1607017","article-title":"Risankizumab versus Ustekinumab for moderate-to-severe plaque psoriasis","volume":"376","author":"Papp","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.12.002_bib112","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1185\/030079907X182112","article-title":"A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12\/23 monoclonal antibody in subjects with plaque psoriasis","volume":"23","author":"Gottlieb","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.12.002_bib113","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4161\/mabs.28376","article-title":"Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab","volume":"6","author":"Aira","year":"2014","journal-title":"mAbs"},{"issue":"11","key":"10.1016\/j.cytogfr.2021.12.002_bib114","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1346-8138.2012.01637.x","article-title":"Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris","volume":"39","author":"Niu","year":"2012","journal-title":"J. Dermatol."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.12.002_bib115","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13129","article-title":"Evaluation of expression pattern of selected genes associated with IL12\/23 signaling paths in psoriatic patients during cyclosporine A therapy","volume":"32","author":"Grabarek","year":"2019","journal-title":"Dermatol. Ther."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.12.002_bib116","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jdermsci.2017.04.005","article-title":"The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells","volume":"87","author":"Oehrl","year":"2017","journal-title":"J. Dermatol. Sci."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.12.002_bib117","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1111\/ijd.12834","article-title":"The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis","volume":"54","author":"Tahvili","year":"2015","journal-title":"Int. J. Dermatol."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.12.002_bib118","first-page":"1538","article-title":"\u2019Psoriasis 1\u2032 reduces T\u2011lymphocyte\u2011mediated inflammation in patients with psoriasis by inhibiting vitamin D receptor\u2011mediated STAT4 inactivation","volume":"46","author":"Gao","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.12.002_bib119","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12013-014-0230-z","article-title":"Disruption of circulating CD4+ T-lymphocyte subpopulations in psoriasis patients is ameliorated by narrow-band UVB therapy","volume":"71","author":"Wang","year":"2015","journal-title":"Cell Biochem. Biophys."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610121000939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610121000939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:01:07Z","timestamp":1761217267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610121000939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":119,"alternative-id":["S1359610121000939"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2021.12.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Participation of interferons in psoriatic inflammation","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2021.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}